A new study finds doctors are appropriately using a genetic test to measure breast cancer recurrence risk and to make tailored treatment recommendations.
Nicole Fawcett is the manager of cancer communication for the University of Michigan Comprehensive Cancer Center, overseeing media relations, marketing, web, internal communication, social media and publications for the center’s research and clinical enterprises. She leads a team of four communicators who produce targeted, innovative communication to meet the Cancer Center’s goals. Nicole joined the University of Michigan Health System in 2003. Prior to that, she was at the Detroit News and at a startup web-based community for people with disabilities.
Part of the national Cancer Moonshot, a new data repository of cancer patients’ analyzed blood samples aims to stimulate translational research across industry and academia.
A new study calls attention to the need for better partnerships between primary care physicians and oncologists.
A new national initiative will change the face of clinical trials for pancreatic cancer through collaboration among researchers, clinicians and pharma.
Understanding who has the highest risk of rare cancers, including squamous cell esophageal cancer, suggests a potential for targeted screening recommendations.
The tiny, scaffoldlike device facilitates early detection of metastatic cancer cells and improves survival, a new study finds.